本頁面由Tiger Trade Technology Pte. Ltd.提供服務

武田製藥

18.24
+0.06000.33%
盤後18.480.2384+1.31%19:30 EDT
成交量:223.30萬
成交額:4,064.87萬
市值:580.49億
市盈率:-57.28
高:18.26
開:18.24
低:18.11
收:18.18
52周最高:18.90
52周最低:12.99
股本:31.83億
流通股本:30.92億
量比:0.84
換手率:0.07%
股息:0.63
股息率:3.44%
每股收益(TTM):-0.3184
每股收益(LYR):-0.3042
淨資產收益率:-2.26%
總資產收益率:2.69%
市淨率:1.22
市盈率(LYR):-59.95

資料載入中...

公司資料

公司名字:
武田製藥
交易所:
NYSE
成立時間:
1781
員工人數:
47029
公司地址:
1-1, Nihonbashi-Honcho 2-chome,Chuo,Tokyo,Japan
郵編:
103-8668
傳真:
- -
簡介:
Takeda Pharmaceutical Company Limited是一家在日本註冊成立的上市公司成立於1925年1月12日。該公司是一家全球研發驅動的生物製藥公司,專註於胃腸道與炎症、神經科學、腫瘤學以及血漿療法和疫苗領域的治療藥物開發。其商業努力集中在關鍵業務領域,研發引擎聚焦於三大核心治療領域,利用內部研究和外部合作夥伴。公司致力於將科學轉化為創新藥物,並通過数字化和先進技術提高運營效率。

董事

名稱
職位
Christophe Weber
Chief Executive Officer and President and Representative Director
Andrew S. Plump
Director and President, Research and Development
Bruce Broussard
External Director
Emiko Higashi
External Director
イアンクラーク
External Director
Jean Luc Butel
External Director
ジョンマラガノア
External Director
Kimberly A. Reed
External Director
Koichiro Kimura
External Director
Koji Hatsukawa
External Director
Masami Iijima
Chair of the Board and External Director
Michel Orsinger
External Director
Miki Tsusaka
External Director
Milano Furuta
Chief Financial Officer and Director
Paul Stoffels
External Director
Steven Gillis
External Director
Yoshiaki Fujimori
External Director

股東

名稱
職位
Christophe Weber
Chief Executive Officer and President and Representative Director
Milano Furuta
Chief Financial Officer and Director
Akiko Amakawa
CEO Chief of Staff
Andrew S. Plump
Director and President, Research and Development
Asuka Miyabashira
President, Japan Pharma Business Unit
Awny Farajallah
Chief Medical Officer
Elaine Shannon
President, Global Supply & Quality
Gabriele Ricci
Chief Data and Technology Officer
Giles Platford
President, International Business Unit
Jennifer Smoter
Chief Communications & Governance Officer
Lauren Duprey
Chief Transformation Officer
Marcello Agosti
Interim Head, Strategy and Portfolio Development
Natalie Furney
Global General Counsel
Nicola Greenway
Chief Human Resources Officer
Ramy Riad
President, Plasma-Derived Therapies Business Unit
Rhonda Pacheco
President, U.S. Business Unit and U.S. Country
Teresa Bitetti
President, Global Oncology Business Unit